CVA Family Office LLC Takes Position in iShares Biotechnology ETF (NASDAQ:IBB)

CVA Family Office LLC purchased a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 375 shares of the financial services provider’s stock, valued at approximately $51,000.

A number of other institutional investors have also added to or reduced their stakes in the stock. Moneta Group Investment Advisors LLC lifted its holdings in iShares Biotechnology ETF by 131,598.4% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 4,469,845 shares of the financial services provider’s stock worth $586,846,000 after purchasing an additional 4,466,451 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in iShares Biotechnology ETF by 159.9% during the 1st quarter. JPMorgan Chase & Co. now owns 1,966,359 shares of the financial services provider’s stock worth $253,975,000 after purchasing an additional 1,209,700 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in iShares Biotechnology ETF by 49.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,568,159 shares of the financial services provider’s stock worth $204,332,000 after purchasing an additional 521,820 shares in the last quarter. Jane Street Group LLC lifted its holdings in iShares Biotechnology ETF by 5.4% during the 4th quarter. Jane Street Group LLC now owns 1,002,554 shares of the financial services provider’s stock worth $131,625,000 after purchasing an additional 50,999 shares in the last quarter. Finally, Itau Unibanco Holding S.A. purchased a new stake in iShares Biotechnology ETF during the 3rd quarter worth about $48,242,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 1.4 %

NASDAQ:IBB opened at $137.79 on Thursday. The business’s 50-day moving average price is $136.42 and its two-hundred day moving average price is $128.75. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $141.16.

iShares Biotechnology ETF Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were issued a $0.126 dividend. The ex-dividend date of this dividend was Thursday, March 21st. This represents a $0.50 annualized dividend and a dividend yield of 0.37%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.